Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRANYLCYPROMINE vs TRASTUZUMAB-DTTB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRANYLCYPROMINE vs TRASTUZUMAB-DTTB: Safety Overview

Metric TRANYLCYPROMINE TRASTUZUMAB-DTTB
Total FAERS Reports 386 497
Deaths Reported 38 28
Death Rate 9.8% 5.6%
Hospitalizations 132 323
Average Patient Age 54.4 yrs 63.0 yrs
% Female Patients 64.1% 73.5%
FDA Approval Date Apr 17, 2018 N/A
Manufacturer Solco Healthcare US, LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription